Efficacy and safety of bronchial arterial infusion chemotherapy combined with transarterial chemoembolization and systemic therapy in hepatocellular carcinoma patients with lung metastases

Documenti analoghi

• Meta‐analysis of randomized controlled trials of external‐beam radiation versus transarterial chemoembolization for hepatocellular carcinoma
  di: Ryan A. Kuehnle, et al.
  Pubblicazione: (2025)
• Efficacy and safety of hepatic arterial infusion chemotherapy combined with donafenib in the treatment of unresectable hepatocellular carcinoma
  di: Tao Wan, et al.
  Pubblicazione: (2024)
• Association of serum AFP trajectories and hepatocellular carcinoma outcomes after hepatic arterial infusion chemotherapy: A longitudinal, multicenter study
  di: Chao An, et al.
  Pubblicazione: (2024)
• Efficacy and safety of atezolizumab plus bevacizumab in patients with portal hypertension for unresectable hepatocellular carcinoma
  di: Takahiro Kinami, et al.
  Pubblicazione: (2024)
• Hepatic arterial infusion chemotherapy, lenvatinib plus programmed cell death protein‐1 inhibitors: A promising treatment approach for high‐burden hepatocellular carcinoma
  di: Shumin Fu, et al.
  Pubblicazione: (2024)